TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer, which is refractory to all currently available treatments and bears dismal prognosis. About 70% of all PDAC cases harbor mutations in the TP53 tumor suppressor gene. Many of those are missense mutations, resulting in abundant product...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2021-06, Vol.118 (23), p.1-9
Hauptverfasser: Maddalena, Martino, Mallel, Giuseppe, Nataraj, Nishanth Belugali, Shreberk-Shaked, Michal, Hassin, Ori, Mukherjee, Saptaparna, Arandkar, Sharathchandra, Rotkopf, Ron, Kapsack, Abby, Lambiase, Giuseppina, Pellegrino, Bianca, Ben-Isaac, Eyal, Golani, Ofra, Addadi, Yoseph, Hajaj, Emma, Eilam, Raya, Straussman, Ravid, Yarden, Yosef, Lotem, Michal, Oren, Moshe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!